RAPT Therapeutics (RAPT) Earnings Date & Reports

A.I. Advisor

published Earnings

RAPT is expected to report earnings to fall 21.92% to -55 cents per share on November 07

RAPT Therapeutics RAPT Stock Earnings Reports

Q3'24

Est.

$-0.55

Q2'24

Beat

by $0.01

Q1'24

Beat

by $0.02

Q4'23

Beat

by $0.06

Q3'23

Missed

by $0.07

The last earnings report on August 08 showed earnings per share of -70 cents, beating the estimate of -72 cents. With 260.10K shares outstanding, the current market capitalization sits at 68.41M.

View a ticker or compare two or three

Compare

RAPT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For RAPT
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical stage immunology-based biopharmaceutical company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

561 Eccles Avenue

Phone

+1 650 489-9000

Employees

131

Web

https://www.rapt.com